Testing version — LOERadar is in active testing. Features and data may change.
PIMAVANSERIN (PIMAVANSERIN) | LOERadar
Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
PIMAVANSERIN
ANDATentative Approval
PIMAVANSERIN | A214750 | TEVA PHARMS USA
Products (1)
#001 — EQ 34MG BASE
▴
CAPSULE;ORAL | TA Date: 2021-04-08 00:00:00
No patent or exclusivity listings for this strength.